Literature DB >> 3261757

Adenosine, deoxyadenosine, and deoxyguanosine induce DNA cleavage in mouse thymocytes.

H Kizaki1, H Shimada, F Ohsaka, T Sakurada.   

Abstract

When thymocytes were cultured with adenosine, deoxyadenosine, or deoxyguanosine at 1 mM for 24 h, DNA cleavage at internucleosomal sites with multiples of approximately 180 bp was induced, followed by lactate dehydrogenase release into the medium. In the presence of coformycin, an adenosine deaminase inhibitor, or formycin B, a purine nucleoside phosphorylase inhibitor, DNA cleavage was induced by these nucleosides at concentrations of less than 50 microM. Other purine and pyrimidine ribo- and deoxyribonucleosides did not induce DNA cleavage or LDH release. Because thymocyte nuclei contain a Ca2+,Mg2+-dependent endonuclease, which preferentially cuts DNA in its linker regions, DNA fragmentation induced by the three purine nucleosides was suggested to occur through increased activity of the endonuclease. The DNA cleavage induced by the nucleosides required protein phosphorylation and synthesis, inasmuch as it was inhibited by an inhibitor of protein kinases, H-7, and by an inhibitor of protein synthesis, cycloheximide. The inhibition of DNA cleavage was accompanied by a reduction in lactate dehydrogenase release, suggesting a causal relationship between DNA cleavage and cell death. The DNA cleavage and subsequent cell lysis might be related to the selective thymocyte deletion observed in patients with adenosine deaminase or purine nucleoside phosphorylase deficiency.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3261757

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  14 in total

1.  Apoptosis as a mechanism of cell death in cultured T lymphoblasts acutely infected with HIV-1.

Authors:  C Terai; R S Kornbluth; C D Pauza; D D Richman; D A Carson
Journal:  J Clin Invest       Date:  1991-05       Impact factor: 14.808

2.  Apoptosis in human thymocytes after treatment with glucocorticoids.

Authors:  M A Nieto; A González; F Gambón; F Díaz-Espada; A López-Rivas
Journal:  Clin Exp Immunol       Date:  1992-05       Impact factor: 4.330

3.  Insights into thymic purine metabolism and adenosine deaminase deficiency revealed by transgenic mice overexpressing ecto-5'-nucleotidase (CD73).

Authors:  R Resta; S W Hooker; A B Laurent; S M Jamshedur Rahman; M Franklin; T B Knudsen; N L Nadon; L F Thompson
Journal:  J Clin Invest       Date:  1997-02-15       Impact factor: 14.808

4.  Adenosine and deoxyadenosine induces apoptosis in oestrogen receptor-positive and -negative human breast cancer cells via the intrinsic pathway.

Authors:  M Hashemi; F Karami-Tehrani; S Ghavami; S Maddika; M Los
Journal:  Cell Prolif       Date:  2005-10       Impact factor: 6.831

5.  Point mutations at the purine nucleoside phosphorylase locus impair thymocyte differentiation in the mouse.

Authors:  F F Snyder; J P Jenuth; E R Mably; R K Mangat
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-18       Impact factor: 11.205

6.  Apoptosis within spontaneously accepted mouse liver allografts: evidence for deletion of cytotoxic T cells and implications for tolerance induction.

Authors:  S Qian; L Lu; F Fu; Y Li; W Li; T E Starzl; J J Fung; A W Thomson
Journal:  J Immunol       Date:  1997-05-15       Impact factor: 5.422

Review 7.  Clinical expression, genetics and therapy of adenosine deaminase (ADA) deficiency.

Authors:  M S Hershfield; F X Arredondo-Vega; I Santisteban
Journal:  J Inherit Metab Dis       Date:  1997-06       Impact factor: 4.982

8.  Adenosine A2A receptor activation protects CD4+ T lymphocytes against activation-induced cell death.

Authors:  Leonóra Himer; Balázs Csóka; Zsolt Selmeczy; Balázs Koscsó; Tímea Pócza; Pál Pacher; Zoltán H Németh; Edwin A Deitch; E Sylvester Vizi; Bruce N Cronstein; György Haskó
Journal:  FASEB J       Date:  2010-04-06       Impact factor: 5.191

9.  Skeletal muscle phenotypically converts and selectively inhibits metastatic cells in mice.

Authors:  Ara Parlakian; Iman Gomaa; Sounkary Solly; Ludovic Arandel; Alka Mahale; Gustav Born; Giovanna Marazzi; David Sassoon
Journal:  PLoS One       Date:  2010-02-18       Impact factor: 3.240

Review 10.  Pentostatin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in lymphoproliferative disorders.

Authors:  R N Brogden; E M Sorkin
Journal:  Drugs       Date:  1993-10       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.